N. Ferguson

发表

Characterization of a Naturally Occurring Infection of a Mycoplasma gallisepticum House Finch-like Strain in Turkey Breeders

N. Ferguson, D. Hermes, V. Leiting, 2003, Avian diseases.

The evaluation of a live Mycoplasma Gallisepticum vaccine candidate and DNA sequence analysis in the molecular epidemiology of Mycoplasma Gallisepticum

N. Ferguson, 2003 .

Safety of Mycoplasma gallisepticum Vaccine Strain 6/85 After Backpassage in Turkeys

M. Zaki, N. Ferguson, V. Leiting, 2004, Avian diseases.

Use of molecular diversity of Mycoplasma gallisepticum by gene-targeted sequencing (GTS) and random amplified polymorphic DNA (RAPD) analysis for epidemiological studies.

N. Ikuta, Maricarmen García, D. Hepp, 2005, Microbiology.

Differentiating Vaccine-Related Fowl Cholera from Naturally Occurring Disease

J. Maurer, Margie D. Lee, N. Ferguson, 2020, Avian Diseases.

Isolation and Characterization of a 6/85-like Mycoplasma gallisepticum from Commercial Laying Hens

M. García, S. Subramanian, N. Ferguson, 2003, Avian diseases.

Safety and Efficacy of the Avirulent Mycoplasma gallisepticum Strain K5054 as a Live Vaccine in Poultry

N. Ferguson, V. Leiting, S. Kleven, 2004, Avian diseases.

Discrepancy between minimal inhibitory concentration to enrofloxacin and mutations present in the quinolone-resistance determining regions of Mycoplasma gallisepticum field strains.

H. Windsor, I. Lysnyansky, N. Ferguson, 2012, Veterinary microbiology.

Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern

S. Gharbia, R. Myers, N. Andrews, 2021, medRxiv.